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on cardiovascular risk in 6470 subjects from
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Lucas S Aparicio1, Lutgarde Thijs2, Kei Asayama2,3, Jessica Barochiner1, Jose´ Boggia4, Yu-Mei Gu2,
Paula E Cuffaro1, Yan-Ping Liu2, Teemu J Niiranen5,6, Takayoshi Ohkubo3,7, Jouni K Johansson5,
Masahiro Kikuya8, Atsushi Hozawa8, Ichiro Tsuji9, Yutaka Imai3, Edgardo Sandoya10, George S Stergiou11,
Gabriel D Waisman1 and Jan A Staessen2,12 on behalf of the International Database
on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators
The absence of an outcome-driven reference frame for self-measured pulse pressure (PP) limits its clinical applicability. In an
attempt to derive an operational threshold for self-measured PP, we analyzed 6470 participants (mean age 59.3 years; 56.9%
women; 22.5% on antihypertensive treatment) from 5 general population cohorts included in the International Database on
HOme blood pressure in relation to Cardiovascular Outcome. During 8.3 years of follow-up (median), 294 cardiovascular
deaths, 393 strokes and 336 cardiac events occurred. In 3285 younger subjects (o60 years), home PP only predicted
all-cause and cardiovascular mortality (Pp0.036), whereas in 3185 older subjects (X60 years) PP predicted total and
cardiovascular mortality (Pp0.0067) and all cardiovascular and coronary events (Pp0.044). However, PP did not substantially
refine risk prediction based on classical risk factors including mean blood pressure (generalized R2 statistic p0.20%). In older
subjects, the adjusted hazard ratios expressing the risk in the upper decile of home PP (X76mmHg) versus the average risk in
whole population were 1.41 (95% confidence interval, 1.09–1.81; P¼0.0081) for all-cause mortality, 1.62 (1.11–2.35;
P¼0.012) for cardiovascular mortality and 1.31 (1.00–1.70; P¼0.047) for all fatal and nonfatal cardiovascular end points
combined. The low number of events precluded an analysis by tenths of the PP distribution in younger participants. In
conclusion, a home PP of X76mmHg predicted cardiovascular outcomes in the elderly with the exception of stroke, whereas
in younger subjects no threshold could be established.
Hypertension Research advance online publication, 20 March 2014; doi:10.1038/hr.2014.45
Keywords: cardiovascular diseases; epidemiology; home blood pressure; pulse pressure; thresholds
INTRODUCTION
Pulse pressure (PP), the difference between systolic and diastolic
blood pressure, depends on left ventricular ejection, the elasticity of
the central arteries, and the timing and intensity of the backward wave
originating at reflection sites in the peripheral circulation. PP widens
in the elderly, because with advancing age systolic blood pressure
continues to rise, whereas the age-related increase in diastolic blood
pressure levels off or even reverses in the fifth decade of life.1 Several
studies showed that PP, derived from the conventionally measured
blood pressure, predicts adverse outcomes in patients with
cardiovascular2 or renal disease3,4 as well as in populations.5–9
Compared with the conventionally measured blood pressure, self-
measurement of blood pressure refines risk stratification.10 To our
knowledge, only one population study examined the risk of stroke
associated with the self-measured PP in Japanese.11 Moreover, current
guidelines for the management of blood pressure do not propose
1The Servicio de Clı´nica Me´dica, Seccio´n Hipertensio´n Arterial, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; 2Studies Coordinating Centre, Research Unit
Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; 3Department of Planning for Drug
Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; 4Centro de Nefrologı´a and Departamento de Fisiopatologı´a,
Hospital de Clı´nicas, Universidad de la Repu´blica, Montevideo, Uruguay; 5Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and
Welfare, Turku, Finland; 6Department of Medicine, Turku University Hospital, Turku, Finland; 7Department of Hygiene and Public Health, Teikyo University School of Medicine,
Tokyo, Japan; 8Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan; 9Department of Public Health,
Tohoku University Graduate School of Medicine, Sendai, Japan; 10Department of Cardiology, Asociacio´n Espan˜ola Primera de Socorros Mutuos, Montevideo, Uruguay; 11Third
Department of Medicine, Hypertension Center, University of Athens, Sotiria Hospital, Athens, Greece and 12Department of Epidemiology, Maastricht University, Maastricht, The
Netherlands
Correspondence: Professor JA Staessen, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, Studies
Coordinating Centre, University of Leuven, Campus Sint Rafae¨l, Kapucijnenvoer Block D, Box 7001, 3000 Leuven, Belgium.
E-mail: jan.staessen@med.kuleuven.be
Received 11 August 2013; revised 15 November 2013; accepted 21 December 2013
Hypertension Research (2014), 1–7
& 2014 The Japanese Society of Hypertension All rights reserved 0916-9636/14
www.nature.com/hr
outcome-driven thresholds for PP.12,13 We therefore assessed the
predictive value of the self-measured home PP in 6470 people
randomly recruited from 5 populations and enrolled in the
International Database of HOme blood pressure in relation to
Cardiovascular Outcome (IDHOCO).
METHODS
Study population
The construction of the IDHOCO database has been described previously.14 At
the time of writing this report, we collected data from 7 prospective population
studies (8912 subjects). All studies received ethical approval. For the present
analysis we discarded two cohorts, because data on cause-specific mortality
were still being collected,15 or because the study included patients instead of a
general population sample.16 Of the 6753 remaining participants, we excluded
283 because o2 home blood pressure readings (n¼ 18) or o2 conventional
blood pressure readings (n¼ 267) were available. Therefore, the number of
participants analyzed totaled 6470, comprising 2520 inhabitants of Ohasama,
Japan;17 2075 Finns representing a nationwide sample;18 811 inhabitants of the
Tsurugaya district, Sendai, Japan;19 399 inhabitants of Montevideo, Uruguay20
and 665 inhabitants of Didima, Greece.21 We categorized participants into
Whites (inhabitants of Finland, Didima and Montevideo) and Asians
(inhabitants of Sendai and Ohasama).
Blood pressure measurement
Clinic blood pressure was measured with a standard mercury sphygmoman-
ometer or an automated device (Elquest USM-700F (Elquest Corporation,
Chiba, Japan), Omron HEM-705CP or Omron Form ABI/PWV (Omron
Healthcare Co., Ltd, Kyoto, Japan)), using the appropriate cuff size. The
average of the first two office blood pressure readings was used for analysis.
Participants recorded their home blood pressure after 2–5min of rest in the
sitting position with validated oscillometric devices (Omron HEM-401C,
Omron HEM-722C, Omron HEM-747, Omron HEM-705CP or SpaceLabs
90207, Spacelabs Healthcare, Snoqualmie, WA, USA), using the appropriate
cuff size. The median number of home blood pressure measurements ranged
from 2 in Montevideo20 to 52 in Ohasama.17 The mean of all available
measurements was used for analysis. Home PP was systolic minus diastolic
blood pressure. Mean arterial pressure was diastolic blood pressure plus one
third of PP. Hypertension was a home blood pressure of at least 135mmHg
systolic or 85mmHg diastolic13 or use of antihypertensive drugs.
Other measurements
We used the baseline questionnaires originally administered in each cohort to
obtain information on each participant’s medical history, intake of medications
and smoking and drinking habits. Subjects using any amount of tobacco or
alcohol in the period of the baseline examination were classified as smokers or
drinkers. Body mass index was body weight in kilograms divided by height in
meters squared. Previous cardiovascular disease included cardiac and cere-
brovascular disorders and peripheral vascular disease. Serum cholesterol and
blood glucose were determined by automated enzymatic methods on venous
blood samples. Diabetes mellitus was a self-reported diagnosis, a fasting or
random blood glucose level of 7.0mmol l1 (126mgdl1) or 11.1mmol l1
(200mgdl1) or higher,22 or use of antidiabetic drugs.
Ascertainment of events
We ascertained vital status and incidence of fatal and non-fatal diseases from
the appropriate sources in each country, as described in detail in a previous
publication.18 Fatal and non-fatal stroke did not include transient ischemic
attacks. Coronary events encompassed death because of ischemic heart disease,
sudden death, non-fatal myocardial infarction, and surgical and percutaneous
coronary revascularization. Cardiac events comprised coronary end points,
fatal and non-fatal heart failure, pacemaker implantation and other cardiac
deaths. The composite cardiovascular end point included cardiovascular
mortality, cerebrovascular and cardiac endpoints. We summarized the
ascertainment and definition of events in each of the cohorts in
Supplementary Table S1. In all outcome analyses, we only considered the first
event per participant within each category.
Statistical analyses
For database management and statistical analysis, we used the SAS software,
version 9.3 (SAS Institute, Cary, NC, USA). For comparison of means and
proportions, we applied the large sample z test and the w2 statistic, respectively.
Statistical significance was an a-level ofo0.05 on two-sided tests. As described
previously,14 we interpolated missing values of body mass index (n¼ 382) and
serum cholesterol (n¼ 133) from the regression slope on age after
stratification for cohort and sex. In subjects with unknown smoking habits
(n¼ 19) and drinking status (n¼ 1216), we set the design variable to the
cohort- and sex-specific mean of the codes (0,1). In the Didima cohort
(n¼ 665), we extrapolated cholesterol values and drinking habits by sex and
age, from data provided by large population cohorts living in a similar
geographical area.23,24
We used Cox regression to compute hazard ratios (HRs). We checked the
proportional hazards assumption and the functional forms of the covariables
by the Kolmogorov-type supremum test, as implemented in the PROC PHREG
procedure of the SAS software. Because the role of PP changes with age, we
stratified all analyses by age 60.25 To compute HRs in tenths of the PP
distribution, we applied the deviation from mean coding.26 This approach
expresses the risk in each tenth relative to the overall risk in the whole study
population and allows computing 95% confidence intervals (CIs) for the HRs
in all tenths without definition of an arbitrary reference group. The HRs for PP
and mean arterial pressure analyzed as continuous variables were standardized
and express the risk associated with a 1-s.d. increase in the independent
variable. We tested heterogeneity in the HRs across subgroups by introducing
the appropriate interaction term in the Cox model. The improvement in
prediction performance gained by adding PP to a model already including the
conventional risk factors was assessed by the net reclassification improvement,27
the integrated discrimination improvement27 and Harrell’s c-statistic.28 We
applied the generalized R2 statistic to assess the risks additionally explained by
PP over and beyond mean arterial pressure and other covariables.29 We
stratified Cox models for cohort and adjusted HRs for baseline characteristics
including sex, age, body mass index, current smoking, alcohol intake, serum
cholesterol, history of cardiovascular disease, diabetes mellitus, antihypertensive
treatment, home pulse rate and mean blood pressure.
RESULTS
Characteristics of participants
The whole study population comprised 3139 Europeans (48.5%) and
3331 Asians (51.5%). Of the 6470 participants, 3680 were women
(56.9%), 2786 (43.1%) had hypertension on home blood pressure
measurement and 1452 (22.4%) were taking blood pressure-lowering
drugs. Mean (±s.d.) age was 59.3±13.5 years. In the whole study
population, home blood pressure averaged 127.2±18.2mmHg
systolic, 76.1±10.0mmHg diastolic, 51.1±12.9mmHg for PP and
93.1±11.9mmHg for mean arterial pressure. At enrollment, 1352
participants (20.9%) were current smokers and 2721 (51.8%)
reported intake of alcohol. Table 1 shows the characteristics of the
participants by age group and sex.
Analysis of younger participants
Incidence of end points. Among 3285 younger subjects, median follow-
up was 8.3 years (5th–95th percentile interval, 7.2–16.8 years). Over
32671 person-years of follow-up, 149 participants died (4.6 per 1000
person-years) and 161 experienced a fatal or non-fatal cardiovascular
complication (5.0 per 1000 person-years). The cause of death was cardio-
vascular in 41 participants, non-cardiovascular in 105 and renal failure in
3. Considering cause-specific first cardiovascular events, 73 subjects
experienced a fatal or non-fatal stroke (14 and 59, respectively) and 90
subjects had a fatal or non-fatal cardiac event (22 and 68).
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Risk associated with home PP. The association between outcome and
PP did not deviate significantly from log linearity (PX0.092). Table 2
shows the standardized HRs associated with home mean blood
pressure and home PP. With adjustments applied for cohort, sex,
age, body mass index, smoking and drinking, serum cholesterol,
home pulse rate, history of cardiovascular disease, diabetes mellitus
and antihypertensive treatment, the home PP significantly predicted
all outcomes, except fatal and non-fatal stroke. After further adjust-
ment for mean arterial pressure, PP only predicted total mortality
(HR, 1.24; 95% CI, 1.01–1.51; P¼ 0.036) and cardiovascular deaths
(HR, 1.47; CI, 1.03–2.10; P¼ 0.033). The results of a similar analysis
on the association between outcome and home PP adjusted for home
systolic blood pressure are shown in Supplementary Table S2. The
small number of events precluded an analysis by tenths of the home
PP distribution in younger participants.
Analysis of older participants
Incidence of end points. Among 3185 older subjects, median follow-
up was 8.2 years (5th–95th percentile interval, 7.2–16.8 years). Over
26 655 person-years of follow-up, 663 participants died (24.9 per 1000
person-years) and 555 experienced a fatal or non-fatal cardiovascular
complication (22.0 per 1000 person-years). The cause of death was
cardiovascular in 253 participants, non-cardiovascular in 395, renal
failure in 10 and unknown in 5. Considering cause-specific first
cardiovascular events, 320 subjects experienced a fatal or non-fatal
stroke (64 and 256, respectively) and 246 subjects had a fatal or non-
fatal cardiac event (127 and 119).
Risk associated with home PP. In older subjects (ageX60 years), the
association between outcome and PP did not deviate significantly
from log linearity (PX0.15). Considering fully adjusted models, the
home PP predicted all of the end points (Pp0.044), except fatal
combined with non-fatal cardiac events (P¼ 0.052) and stroke
Table 1 Baseline characteristics of participants by age group
Characteristic o60 years X60 years
Number of subjects (%) 3285 3185
Women 1871 (56.9) 1809 (56.8)
Asian 1225 (37.3) 2106 (66.1)
Smokers 873 (26.6) 479 (15.1)
Drinking alcohol 1540 (58.8) 1181 (44.8)
Hypertension 882 (26.9) 1904 (59.8)
On antihypertensive treatment 389 (11.9) 1063 (33.4)
Diabetes mellitus 170 (5.2) 376 (11.8)
Cardiovascular disorders 125 (3.8) 539 (16.9)
Mean (±s.d.) characteristic
Age, years 48.3 (8.6) 70.5 (6.7)
Body mass index, kgm2 25.7 (4.2) 25.2 (4.3)
Conventional blood
pressure, mmHg
Systolic 127.5 (18.4) 140.6 (20.3)
Diastolic 78.8 (11.9) 79.3 (11.6)
Pulse pressure 48.7 (12.9) 61.3 (15.1)
Mean arterial pressure 95.0 (13.1) 99.7 (13.3)
Self-recorded pressure
Systolic 120.1 (15.7) 134.5 (17.8)
Diastolic 75.2 (10.4) 77.1 (9.5)
Pulse pressure 44.9 (8.9) 57.4 (13.4)
Mean arterial pressure 90.1 (11.7) 96.2 (11.2)
Self-recorded pulse rate,
beats min1
70.7 (9.0) 67.5 (8.9)
Serum cholesterol, mmol l1 5.57 (1.1) 5.42 (1.1)
Hypertension was a home blood pressure of at least 135 mmHg systolic or 85mm Hg diastolic
or use of antihypertensive drugs. Diabetes mellitus was a self-reported diagnosis, a fasting or
random blood glucose level of 7.0 mmol l1 (126 mgdl1) or 11.1mmol l1 (200mgdl1) or
higher, or use of antidiabetic drugs. All differences between age groups were significant
(Po0.0001) with the exception of conventional diastolic blood pressure (P¼0.10) and the
proportion of women (P¼0.90).
Table 2 Standardized hazard ratios relating outcomes to home pulse pressure and mean arterial pressure by age group
Age o60 years Age X60 years
Hazard ratios Hazard ratios
End point Model N1 events Mean pressure Pulse pressure N1 events Mean pressure Pulse pressure
Mortality
All causes A 149 1.24 (1.01–1.51)* 1.28 (1.08–1.52)w 663 1.04 (0.95–1.13) 1.14 (1.05–1.25)w
FA 1.08 (0.86–1.37) 1.24 (1.01–1.51)* 0.96 (0.86–1.06) 1.17 (1.06–1.30)w
Cardiovascular A 41 1.44 (0.98–2.10) 1.56 (1.15–2.11)w 253 1.08 (0.94–1.24) 1.22 (1.07–1.40)w
FA 1.15 (0.75–1.77) 1.47 (1.03–2.10)* 0.96 (0.82–1.14) 1.25 (1.06–1.47)w
Fatal plus non-fatal events
All cardiovascular A 161 1.50 (1.24–1.80)y 1.34 (1.15–1.56)y 555 1.26 (1.15–1.38)y 1.25 (1.14–1.36)y
FA 1.35 (1.09–1.68)w 1.18 (0.98–1.41) 1.18 (1.06–1.32)w 1.14 (1.02–1.27)*
Cardiac A 90 1.66 (1.31–2.10)y 1.38 (1.15–1.66)z 246 1.01 (0.88–1.16) 1.12 (0.98–1.27)
FA 1.50 (1.12–2.00)w 1.15 (0.92–1.45) 0.91 (0.77–1.09) 1.18 (1.00–1.39)
Coronary A 76 1.54 (1.20–2.00)z 1.26 (1.03–1.55)* 175 1.03 (0.87–1.21) 1.15 (0.99–1.34)
FA 1.49 (1.08–2.06)* 1.05 (0.81–1.35) 0.90 (0.73–1.11) 1.22 (1.00–1.49)*
Stroke A 73 1.25 (0.94–1.68) 1.31 (1.01–1.71)* 320 1.51 (1.34–1.70)y 1.37 (1.21–1.56)y
FA 1.13 (0.82–1.56) 1.25 (0.94–1.68) 1.42 (1.23–1.63)y 1.14 (0.98–1.32)
Hazard ratios, presented with 95% confidence interval, express the risk associated with a 1-s.d. (11.7mmHg and 11.2mmHg in subjects o60 years and X60 years, respectively) increase in
mean home blood pressure or a 1-s.d. (8.8mmHg and 13.4mmHg) increase in home pulse pressure. All models were stratified for cohort and adjusted for sex, age, body mass index, smoking
and drinking, serum cholesterol, home pulse rate, diabetes mellitus, history of cardiovascular disease, and antihypertensive treatment. Adjusted models (A) include either the mean blood pressure
or pulse pressure, while fully adjusted models (FA) include both mean blood pressure and pulse pressure in addition to the aforementioned covariates. Significance of the hazard ratios: *Po0.05,
wPo0.01, zPo0.001, and yPo0.0001.
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(P¼ 0.083; Table 2). Supplementary Table S2 shows the results of a
similar analysis using systolic blood pressure instead of mean blood
pressure. The generalized R2 statistics for adding home PP as a
predictor of outcome over and beyond mean arterial pressure was
0.20% for cardiovascular mortality and 0.14% for fatal combined with
non-fatal cardiovascular events (Table 3).
Figure 1 shows the multivariable-adjusted HRs comparing the risk
in tenths of the distribution of home PP versus the average risk in all
Table 3 Predictive value of the Cox regression models in participants aged 60 or more
Cardiovascular mortality Cardiovascular events
Models
Likelihood
ratio P-value
R2
(%)
NRI
(%)
IDI
(%)
C
(%)
Likelihood
ratio P-value
R2
(%)
NRI
(%)
IDI
(%)
C
(%)
Basic model 332.3 y 9.91 y 52.2 327.2 y 9.80 y y y
Mean home blood pressure added to basic model 1.2 0.27 0.03 1.11 0.20 0.04 24.8 o0.0001 0.70 17.6 5.6 0.92
Systolic home pressure added to basic model 4.6 0.031 0.13 6.70 0.05 0.35 29.7 o0.0001 0.84 21.9 7.6 1.22
Home pulse pressure added to basic model 8.2 0.0042 0.23 7.81 1.50 0.74 21.2 o0.0001 0.60 11.1 5.9 0.96
Home pulse pressure added to basic model
also including mean blood pressure
7.2 0.0074 0.20 13.4 2.50 0.74 5.0 0.026 0.14 4.3 1.8 0.31
Home pulse pressure added to basic model
also including systolic blood pressure
3.7 0.053 0.11 6.31 2.25 0.44 0.00 0.96 0.00 5.9 0.0 0.00
The basic model included cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, home pulse rate, diabetes mellitus, history of cardiovascular disease and antihypertensive
treatment. P-values are for the improvement of the fit across nested models. Values are likelihood ratios, generalized R2-statistics, net reclassification improvement (NRI), relative integrated
discrimination improvement (IDI) and the improvements in Harrell’s C statistic (C) by adding mean home blood pressure, home systolic blood pressure or home pulse pressure to the reference
model.
0.0
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Figure 1 Multivariable-adjusted hazard ratios (95% confidence intervals) by tenths of the home pulse pressure distribution in 3185 older subjects
(X60 years). The hazard ratios express the risk in tenths of the distribution compared with the average risk in all elderly and were adjusted for cohort, sex,
age, body mass index, smoking and drinking, serum cholesterol, home pulse rate, home mean blood pressure, diabetes mellitus, history of cardiovascular
disease and antihypertensive treatment. The number of events and incidence rates (in percent) are also given for each tenth. P-values are provided for the
hazard ratio in the top tenth.
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of the elderly. The HRs reached statistical significance in the ninth
(1.27; CI, 1.00–1.61; P¼ 0.046) and in the upper (1.41; CI, 1.09–1.81;
P¼ 0.0081) tenths for total mortality, and in the upper tenth for
cardiovascular mortality (1.62; CI, 1.11–2.35; P¼ 0.012), all cardio-
vascular events (1.31; CI, 1.00–1.70; P¼ 0.047), all cardiac events
(1.57; 1.08–2.30; P¼ 0.018) and all coronary events (1.78; CI, 1.14–
2.78; P¼ 0.011). The risk of stroke in the upper tenth did not exceed
the average risk among all elderly (HR, 1.17; CI, 0.81–1.70; P¼ 0.40).
PP in the ninth and top tenth of the distribution of home PP averaged
71.3mmHg (range, 67.8–75.9mmHg) and 84.9mmHg (range, 76.0–
125.8mmHg).
Sensitivity analyses. We checked the consistency of our results for
cardiovascular mortality and for fatal and non-fatal cardiovascular
events combined (Table 4), according to various baseline character-
istics in older participants. The HRs expressing the risk associated
with a 1-s.d. (13.1mmHg) increase in home PP were not statistically
different between subgroups (0.19pPp0.93). In addition, our results
did not materially change after excluding one cohort at a time. Finally,
we repeated our analyses using tenths of the distribution of the
conventionally measured PP instead of home PP. PP in the top tenth
of the distribution of the conventionally measured PP averaged
90.6mmHg (range, 81.0–159.0mmHg). With adjustments applied
as before, this level of conventional PP was associated with increased
total mortality (HR, 1.36; CI, 1.10–1.70; P¼ 0.006), but not with
excess cardiovascular mortality (HR, 1.21; CI, 0.86–1.71; P¼ 0.27), or
cardiovascular (HR, 1.06; CI, 0.83–1.36; P¼ 0.63) or cardiac (HR,
1.13; CI, 0.79–1.63; P¼ 0.49) events.
DISCUSSION
To our knowledge, our current study provides the first population-
based findings on the incremental value of self-measured PP in the
prediction of mortality and cardiovascular events over and beyond
traditional risk factors, including mean arterial pressure, the steady
component of blood pressure.5 Below age 60, home PP predicted all-
cause and cardiovascular mortality. From age 60 onwards, home PP
predicted total and cardiovascular mortality and all cardiovascular
and coronary events. In the elderly, a PP of X76mmHg was
associated with adverse cardiovascular outcomes, but not including
stroke. However, PP did not substantially refine risk prediction based
on classical risk factors including mean arterial pressure.
The only prior outcome-based population study reporting on the
predictive value of self-measured PP was the Ohasama study.11,30
Among 2369 subjects without a history of stroke (mean age, 59 years;
60% women), 238 strokes occurred during 11.7 years of follow-up.11
In line with our current findings, PP was a weaker predictor of stroke
than mean arterial pressure.11 Among 1913 Ohasama participants,
followed up for 8.3 years, 93 died because of cardiovascular disease.30
Each 10mmHg increment in the home PP was associated with a
higher risk of cardiovascular mortality (HR, 1.37; CI, 1.14–1.55;
P¼ 0.001).30 The analysis focusing on stroke was adjusted for sex, age,
smoking, use of antihypertensive medication, hypercholesterolemia,
diabetes mellitus and history of heart disease.11 The analysis of
cardiovascular mortality was adjusted for the same covariables plus
obesity.30 Obesity was a body mass index exceeding 25.0 kgm2, not
30 kgm2, and the overall prevalence was 20.5%, which seems to be
higher than expected for Japanese. The Ohasama results are not
representative for other ethnicities and were not adjusted for body
mass index, home pulse rate and drinking status. However, our
current study that includes 48.5% Whites and the Ohasama
results11,30 are consistent with the concept that PP, representing the
pulsatile component of blood pressure, is the dominant predictor of
cardiac events,31 whereas mean arterial pressure, representing the
steady component of blood pressure, is the dominant predictor of
stroke.6,32
Several longitudinal population studies19–21,33 attempted to
establish cardiovascular prognosis and diagnostic cutoff limits for
blood pressure components derived from home-based measurements.
However, up to this day, they did not address outcome-driven
thresholds for home PP. To our knowledge, the PARTAGE
(Predictive Values of Blood Pressure and Arterial Stiffness in
Institutionalized Very Aged Population) study34 is the only study
that reported on the 2-year predictive value of the self-measured PP in
a cohort of patients. The study included 1126 very old participants
(77.6% women; mean age, 88 years), who were living in French and
Italian nursing homes. At baseline, participants measured their blood
pressure following the ‘rule of 3’ (three measurements with intervals of
1min in the morning and evening for 3 consecutive days). During
follow-up, 247 participants died and 228 experienced a major
cardiovascular event. The self-measured PP averaged 65mmHg, but
was not a significant predictor either of total mortality (HR for
þ 10mmHg, 0.90; CI, 0.81–1.00; P¼ 0.057) or of cardiovascular
events (HR, 0.98; CI, 0.89–1.09; P¼ 0.74). Several cross-sectional
studies in patients addressed the association between intermediate
signs of target organ damage and PP. However, results obtained in
patients, in particular from cross-sectional studies, are not
representative of populations and are not relevant to the research
question addressed in our current manuscript.
The Seventh Report of the Joint National Committee on Preven-
tion, Detection, Evaluation, and Treatment of High Blood Pressure12
Table 4 Standardized hazard ratios for cardiovascular mortality and
cardiovascular events in older participants in relation to home pulse
pressure in different strata
Subgroup At risk (n) Events (n) Hazard ratio (CI) P-value
Cardiovascular mortality
All participants 3185 253 1.25 (1.06–1.45) 0.0067
Women 1809 114 1.10 (0.85–1.43) 0.46
Men 1376 139 1.43 (1.15–1.77) 0.0014
Hypertension 1904 186 1.30 (1.08–1.55) 0.0045
Normotension 1281 67 1.04 (0.62–1.73) 0.89
Treated 1063 125 1.21 (0.96–1.52) 0.11
Untreated 2114 127 1.27 (1.01–1.60) 0.044
Whites 1079 74 1.04 (0.76–1.41) 0.82
Asians 2106 179 1.37 (1.12–1.68) 0.0022
Fatal and non-fatal cardiovascular events
All participants 3185 555 1.14 (1.02–1.27) 0.025
Women 1809 252 1.03 (0.87–1.23) 0.71
Men 1376 303 1.23 (1.06–1.42 0.0069
Hypertension 1904 410 1.15 (1.01–1.30) 0.032
Normotension 1281 145 1.24 (0.89–1.74) 0.21
Treated 1063 262 1.08 (0.92–1.27) 0.33
Untreated 2114 291 1.17 (1.00–1.36) 0.057
Whites 1079 197 1.01 (0.83–1.22) 0.91
Asians 2106 358 1.21 (1.05–1.40) 0.0087
Hazard ratios (95% confidence intervals (CIs) were calculated in subjects X60 years and
express the risk associated with a 1-s.d. (13.1mmHg) increase in home pulse pressure. All
models were stratified for cohort and adjusted for sex, age, body mass index, smoking and
drinking, serum cholesterol, home pulse rate and mean blood pressure, diabetes mellitus,
history of cardiovascular disease and antihypertensive treatment. Hazard ratios did not differ
significantly between subgroups (P40.19). Whites were recruited in Didima, Finland and
Montevideo and Asians in Ohasama and Sendai.
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proposed that PP is only marginally stronger than systolic blood
pressure for risk stratification in individuals over age 60, and that
under age 60, PP is not predictive. The 2007 European guideline35
stated that PP is a derived measure, which combines the imprecision
of the original systolic and diastolic measurements and that, although
levels of 50–55mmHg have been suggested, no practical cutoff values
separating PP normality from abnormality were available. The 2013
European guideline13 increased this threshold to 60mmHg without
any justification. Our current analyses established that below age 60,
total and cardiovascular mortality were log linearly associated with
home PP, but that due to the small number of events no outcome-
driven threshold could be established. In the elderly, home PP
predicted all end points with the exception of stroke, but the
refinement of prognostication over and beyond traditional risk
factors and the steady component of blood pressure was small.
Among elderly, the threshold delineating increased risk of death is
around 68mmHg and for fatal combined with non-fatal
cardiovascular events 76mmHg. Using the same approach for
conventional PP in elderly participants identified a threshold of
around 91mmHg for an increased risk of cardiovascular
complications.
The current sensitivity analysis showed that home PP was a
significant predictor of cardiovascular mortality and cardiovascular
events in Asians but not in Whites. However, the HRs were not
significantly different between the two races (Table 4) indicating that
this finding might be due to chance.
The strong points of our current report are the relatively large
sample size and the large number of events, which occurred over a
median follow-up of 48 years. However, our current results must
also be interpreted within the context of their potential limitations.
First, the anthropometric characteristics and the time of recruitment
within the IDHOCO database differed between cohorts, and clinic
and home BP measurements were not standardized in terms of device
type, number of measurements and intervals between readings.
Second, our analysis rested on five population-based cohorts with
an overrepresentation of Asians and Caucasians, and might not be
representative for other ethnic groups, in particular Blacks. Third, for
a limited number of covariables, we used interpolated data. However,
sensitivity analyses from which we excluded the Didima cohort were
confirmatory. Finally, the generalized R2 is not a perfect measure of
the variation explained by Cox models. Nevertheless, a measure of
explained variance is essential for the correct interpretation of the
prognostic value of a risk factor, because P-values of HRs do not
necessarily reflect clinical significance.
In conclusion, home PP adds little information on cardiovascular
outcomes below age 60 based on our observations in randomly
recruited people. In the elderly, home PP is a weak risk factor with
levels below 68mmHg probably being innocuous. However, using
this threshold in clinical practice might be of little value, because
home PP does not substantially enhance risk stratification over and
beyond the steady component of the blood pressure level and other
cardiovascular risk factors. Our current findings might inform future
guidelines and lead to a consensus about a threshold for PP that is
justified by health outcomes.
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Table S1.  Ascertainment of Events and International Classification of Diseases Codes (10th edition) applied in each cohort  
 Ohasama Finn-Home Tsurugaya Didima Montevideo 
Ascertainment of events      
Fatal Death certificates Death certificates 
NHI database 
Medical records 
Death certificates Death certificates 
Non-fatal 
Stroke registration 
system 
Medical records 
Hospital discharge 
register 
NHI database 
Medical records 
Interviews 
Medical records 
Interviews 
Medical records 
ICD-10 codes, if available        
Stroke  I60–I64 I61, I63 I60-I64 Investigator-defined Investigator-defined 
Sudden death I46, R96 I46, R96 I46, R96 Investigator-defined Investigator-defined 
Heart failure I50, J81 I50 I50 Investigator-defined Investigator-defined 
Peripheral arterial disease I70–I74 I70-I74 I70-I74 Investigator-defined Investigator-defined 
Ischemic heart disease I21–I25 I21-I25 I21-I25 Investigator-defined Investigator-defined 
Other cardiac death 
I05, I11, I34, I35, I38, 
I44, I47–I49, I99 
I11 - Investigator-defined Investigator-defined 
ICD-10, The International Statistical Classification of Diseases, 10
th
 revision; NHI, National Health Insurance 
 
Table S2.  Standardized Hazard Ratios Relating Outcomes to Home Pulse Pressure and Systolic Pulse Pressure by Age Group.  
Endpoint Model  
Age <60 years   Age ≥60 years  
N° Events 
Hazard Ratios   
N° Events 
Hazard Ratios  
Systolic Pressure Pulse Pressure  Systolic Pressure Pulse Pressure 
Mortality          
All causes   A  149  1.30 (1.08–1.57)† 1.28 (1.08–1.52)†  663  1.09 (1.00–1.19)* 1.14 (1.05–1.25)†  
  FA   1.12 (0.81–1.53) 1.19 (0.90–1.57)   0.93 (0.79–1.09) 1.22 (1.03–1.43)* 
Cardiovascular  A  41  1.60 (1.12–2.29)* 1.56 (1.15–2.11)†  253  1.17 (1.02–1.34)* 1.22 (1.07–1.40)†  
  FA   1.20 (0.68–2.15) 1.37 (0.83–2.26)   0.94 (0.73–1.22) 1.29 (1.00–1.66)  
Fatal Plus Nonfatal Events          
All cardiovascular   A  161  1.51 (1.27–1.79)§ 1.34 (1.15–1.56)§  555  1.29 (1.18–1.42)§  1.25 (1.14–1.36)§  
  FA   1.49 (1.12–2.00)† 1.01 (0.78–1.30)   1.30 (1.09–1.54)† 1.00 (0.84–1.19) 
Cardiac  A  90  1.61 (1.30–2.00)§ 1.38 (1.15–1.66)‡  246  1.07 (0.93–1.22) 1.12 (0.98–1.27) 
  FA   1.71 (1.16–2.54)† 0.94 (0.67–1.32)   0.87 (0.66–1.14) 1.27 (0.96–1.67) 
Coronary  A  76  1.47 (1.16–1.85)† 1.26 (1.03–1.55)*  175  1.09 (0.93–1.27) 1.15 (0.99–1.34) 
  FA   1.71 (1.11–2.63)* 0.86 (0.59–1.25)   0.85 (0.61–1.18) 1.33 (0.96–1.84) 
Stroke    A  73  1.34 (1.00–1.80)* 1.31 (1.01–1.71)*  320  1.54 (1.36–1.74)§ 1.37 (1.21–1.56)§ 
  FA   1.18 (0.77–1.81) 1.18 (0.80–1.74)   1.74 (1.39–2.17)§ 0.86 (0.69–1.08) 
Hazard ratios, presented with 95% confidence interval, express the risk associated with a 1-SD (15.7 mm Hg and 17.8 mm Hg in subjects <60 years and ≥60 years, re-
spectively)  increase in systolic home  blood pressure or a 1-SD (8.8 mm Hg and 13.4 mm Hg) increase in home pulse pressure.  All models were stratified for cohort and 
adjusted for sex, age, body mass index, smoking and drinking, serum cholesterol, home pulse rate, diabetes mellitus, history of cardiovascular disease, and antihyperten-
sive treatment.  Adjusted models (A) include either the mean blood pressure or pulse pressure, while fully adjusted models (FA) include both mean blood pressure and 
pulse pressure in addition to the aforementioned covariates. Significance of the hazard ratios: * P<0.05, † P<0.01, ‡ P<0.001, and § P<0.0001.   
 
